These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36894193)

  • 21. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-criteria manifestations in the presence of antiphospholipid antibodies in a paediatric cohort.
    Morán-Álvarez P; Andreu-Suárez Á; Caballero-Mota L; Gassiot-Riu S; Berrueco-Moreno R; Calzada-Hernández J; Antón-López J; Vázquez-Díaz M; Boteanu A
    Rheumatology (Oxford); 2022 Nov; 61(11):4465-4471. PubMed ID: 35137009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
    Kato M; Hisada R; Atsumi T
    Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
    Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying additional risk factors for arterial and venous thrombosis among pediatric antiphospholipid antibodies carriers.
    Sloan E; Wright T; Zuo Y
    Lupus; 2021 Apr; 30(5):828-832. PubMed ID: 33736541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients.
    Islabão AG; Mota LMH; Ribeiro MCM; Arabi TM; Cividatti GN; Queiroz LB; Andrade DC; Sakamoto AP; Trindade VC; Novak GV; Molinari BC; Campos LM; Aikawa NE; Pereira RMR; Terreri MT; Magalhães CS; Marini R; Gomes HR; Silva MF; Oliveira SK; Sztajnbok FR; Sacchetti SB; Bica BE; Sena EG; Moraes AP; Santos MC; Robazzi TC; Spelling PF; Scheibel IM; Cavalcanti AS; Naka EN; Guimarães LJ; Santos FP; Sampaio MC; Bonfá E; Silva CA;
    Autoimmun Rev; 2020 Dec; 19(12):102693. PubMed ID: 33164791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
    Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
    da Rosa GP; Sousa-Pinto B; Ferreira E; Araújo O; Barilaro G; Bettencourt P; Cervera R; Espinosa G
    Arthritis Res Ther; 2022 Jan; 24(1):9. PubMed ID: 34980238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Description of damage in different clusters of patients with antiphospholipid syndrome.
    Uludağ Ö; Çene E; Gurel E; Çetin Ç; Bektaş M; Yalçınkaya Y; Diz-Küçükkaya R; Gül A; Inanç M; Artim-Esen B
    Lupus; 2022 Apr; 31(4):433-442. PubMed ID: 35166607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
    Amoura Z; Bader-Meunier B; Bal Dit Sollier C; Belot A; Benhamou Y; Bezanahary H; Cohen F; Costedoat-Chalumeau N; Darnige L; Drouet L; Elefant E; Harroche A; Lambert M; Martin T; Martin-Toutain I; Mathian A; Mekinian A; Pineton De Chambrun M; de Pontual L; Wahl D; Yelnik C; Zuily S;
    Rev Med Interne; 2023 Sep; 44(9):495-520. PubMed ID: 37735010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.
    Tarr T; Lakos G; Bhattoa HP; Soltesz P; Shoenfeld Y; Szegedi G; Kiss E
    Clin Rev Allergy Immunol; 2007 Apr; 32(2):131-7. PubMed ID: 17916982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome.
    Rosa Dos Santos AP; de Oliveira Vaz C; Hounkpe BW; Jacintho BC; Oliveira JD; Tripiquia Vechiatto Mesquita GL; Pereira Dos Santos I; Annichino-Bizzacchi J; Appenzeller S; de Moraes Mazetto Fonseca B; Orsi FA
    Lupus; 2022 Aug; 31(9):1067-1077. PubMed ID: 35612283
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.
    Del Ross T; Ruffatti A; Cuffaro S; Tonello M; Calligaro A; Favaro M; Facchinetti M; Hoxha A; Punzi L
    Thromb Res; 2015 Nov; 136(5):883-6. PubMed ID: 26410418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.